ID

22131

Description

Study part: 60 Days Post- Treatment Concomitant medications. A phase III multinational, randomized, single-blind study of recombinant humanized anti-p185HER2 monoclonal antibody (rhuMAb HER2) in patients with HER2/neu overexpression who have not received prior cytotoxic chemotherapy for metastatic breast cancer. "Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche"

Mots-clés

Versions (2)
  1. 20/05/2017 20/05/2017 -
  2. 15/03/2021 15/03/2021 - Dr. rer. medic Philipp Neuhaus
Détendeur de droits

Roche

Téléchargé le

20 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

60 DAYS POST-TREATMENT CONCOMITANT MEDICATIONS Roche H0650g Breast Cancer

Anglais

60 DAYS POST-TREATMENT CONCOMITANT MEDICATIONS

1 Formulaires  
CONCOMITANT MEDICATIONS
Description

CONCOMITANT MEDICATIONS

Alias
UMLS CUI-1
C2347852
PATIENT INT.
Description

Patient initial

Type de données

text

Alias
UMLS CUI [1]
C2986440
PATIENT NUMBER
Description

Patient id

Type de données

integer

Alias
UMLS CUI [1]
C2348585
DRUG NAME
Description

concomitant medication

Type de données

text

Alias
UMLS CUI [1]
C2347852
INDICATION- PROPHYLAXIS ?
Description

Prophylaxis Indication medication

Type de données

boolean

Alias
UMLS CUI [1,1]
C0199176
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0013227
INDICATION
Description

Indication medication

Type de données

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0013227
TOTAL DAILY DOSE- PRN ?
Description

TOTAL DAILY DOSE

Type de données

boolean

Alias
UMLS CUI [1]
C2348070
TOTAL DAILY DOSE (units)
Description

TOTAL DAILY DOSE

Type de données

float

Alias
UMLS CUI [1]
C2348070
DATE OF FIRST DOSE
Description

therapy start date

Type de données

date

Alias
UMLS CUI [1]
C1531783
FIRST DOSE- CONTINUING?
Description

CONCOMITANT MEDICATIONS

Type de données

boolean

Alias
UMLS CUI [1]
C2347852
DATE OF FINAL DOSE
Description

therapy end date

Type de données

date

Alias
UMLS CUI [1]
C1531784
FINAL DOSE- ONGOING?
Description

CONCOMITANT MEDICATIONS

Type de données

boolean

Alias
UMLS CUI [1]
C2347852
Retour au début de la page

Similar models

60 DAYS POST-TREATMENT CONCOMITANT MEDICATIONS

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
CONCOMITANT MEDICATIONS
C2347852 (UMLS CUI-1)
Patient initial
Item
PATIENT INT.
text
C2986440 (UMLS CUI [1])
Patient id
Item
PATIENT NUMBER
integer
C2348585 (UMLS CUI [1])
concomitant medication
Item
DRUG NAME
text
C2347852 (UMLS CUI [1])
Prophylaxis Indication medication
Item
INDICATION- PROPHYLAXIS ?
boolean
C0199176 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Indication medication
Item
INDICATION
text
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
TOTAL DAILY DOSE
Item
TOTAL DAILY DOSE- PRN ?
boolean
C2348070 (UMLS CUI [1])
TOTAL DAILY DOSE
Item
TOTAL DAILY DOSE (units)
float
C2348070 (UMLS CUI [1])
therapy start date
Item
DATE OF FIRST DOSE
date
C1531783 (UMLS CUI [1])
CONCOMITANT MEDICATIONS
Item
FIRST DOSE- CONTINUING?
boolean
C2347852 (UMLS CUI [1])
therapy end date
Item
DATE OF FINAL DOSE
date
C1531784 (UMLS CUI [1])
CONCOMITANT MEDICATIONS
Item
FINAL DOSE- ONGOING?
boolean
C2347852 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial